避孕药市场按类型、给药途径、年龄层、分销管道和地区划分

2025 年全球避孕药具市场规模估计为 197.9 亿美元，预计到 2032 年将达到 471.4 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 13.2%。

数字。 2025年各地区避孕市场占有率（%）

过去几十年来，全球避孕药市场一直稳定成长。避孕药，俗称避孕药，含有合成的女性荷尔蒙雌激素和黄体素。透过口服来抑制排卵和改变子宫颈黏液和子宫内膜以防止怀孕。对计划生育态度的转变、对意外怀孕的日益担忧、对性健康的认识的提高以及对避孕选择的更严格的监管规范都在推动全球对避孕药具的需求。此外，女性劳动参与率的提高和怀孕时间的延迟也进一步提高了口服避孕药的接受度。

市场动态：

妇女识字率的提高和妇女权力的增强是推动避孕市场向前发展的主要因素。随着人们对妇女生殖健康和权利意识的提高，人们广泛接受使用避孕药来延迟或计划怀孕。快速的都市化、不断变化的生活方式以及现代医疗保健的便捷，使得越来越多的女性选择口服避孕药。同时，功效更高、副作用更少的新产品的出现以及满足避孕方面未满足的医疗需求的技术创新正在为市场参与者创造丰厚的成长机会。然而，替代性计划生育方法和避孕设备的可用性，以及与荷尔蒙药物相关的副作用（如血栓、忧郁症和体重减轻）正在阻碍市场的成长。此外，社会耻辱和宗教保留继续抑制某些地区对避孕药具的需求。

本研究的主要特点

• 本报告对全球避孕药具市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率(CAGR)。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要市场参与者采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球避孕药具市场的主要企业概况。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球避孕药具市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 透过分析全球避孕药具市场所使用的各种策略矩阵，相关人员将发现决策更加容易。

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
• 避孕药具日益普及
• 加强政府力度，促进计划生育和避孕措施的普及
  • 限制因素
• 与锭剂相关的副作用
• 血栓和心血管疾病的风险
  • 机会
• 新兴国家的需求不断成长
• 选择避孕的女性人口不断增加
• 主要亮点
• 近期动态
• PEST分析
• 波特分析
• 最近的产品核可/发布
• 合併、收购和合作

4. 全球避孕市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020-2032 年全球避孕药市场（按类型）

• 合併避孕药
• 单锭剂
• 多锭剂
• 延长週期药丸
• 荷尔蒙避孕药
• 仅含黄体素的避孕药
• 事后紧急避孕药
• levonorgestrel类
• 醋酸乌利司他碱

6. 2020-2032 年全球避孕药市场（依给药途径划分）

• 口服
• 注射
• 在子宫内
• 阴道
• 其他（补丁等）

7. 2020-2032 年全球避孕市场（依年龄层划分）

• 青年
• 成人

8. 2020-2032 年全球避孕药市场（依分销管道划分）

• 网路药局
• 医院药房
• 零售药局

9. 2020-2032 年全球避孕药市场（按地区）

• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东
• 非洲

第十章 竞争格局

• 公司简介
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck &Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

第 11 章 章节

• 参考
• 调查方法
• 关于出版商

Global Contraceptives Market is estimated to be valued at USD 19.79 Bn in 2025 and is expected to reach USD 47.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2032.

Figure. Contraceptives Market Share (%), By Region 2025

Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.

Market Dynamics:

Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.

Key Features of the Study:

• This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
• It profiles key players in the global contraceptive market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market

Detailed Segmentation:

• Global Contraceptive Market, By Type
  • Combination Contraceptives
  • Monophasic pills
  • Multiphasic pills
  • Extended-cycle pills
  • Hormonal Contraceptives
  • Progestin-Only Pills
  • Emergency Contraceptives
  • Levonorgestrel-based
  • Ulipristal acetate-based
• Global Contraceptive Market, By Route of Administration
  • Oral
  • Injectable
  • Intrauterine
  • Vaginal
  • Others (Patches, etc.)
• Global Contraceptive Market, By Age Group
  • Adolescents
  • Adults
• Global Contraceptive Market, By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
• Global Contraceptive Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck & Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing popularity of contraceptive drugs
• Growing government initiatives for promoting access to family planning and contraceptives
  • Restraints
• Side effects associated with pills
• Risks of blood clots and cardiovascular diseases
  • Opportunities
• Growing demand in developing countries
• Growing female population opting for contraceptive drugs
• Key Highlights
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Contraceptive Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Contraceptive Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Combination Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Monophasic pills
• Multiphasic pills
• Extended-cycle pills
• Hormonal Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Progestin-Only Pills
• Emergency Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Levonorgestrel-based
• Ulipristal acetate-based

6. Global Contraceptive Market, By Route of Administration, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Intrauterine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Vaginal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others (Patches, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Contraceptive Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Contraceptive Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Contraceptive Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Bayer AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Teva Pharmaceutical Industries
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Merck & Co.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us